Vise Technologies, Inc. Novartis Ag Transaction History

Vise Technologies, Inc.

$771 Million
Q3 2024

A detailed history of Vise Technologies, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Vise Technologies, Inc. holds 16,705 shares of NVS stock, worth $1.64 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

16,705

Previous 16,365 2.08%

Holding current value

$1.64 Million

Previous $1.74 Million 10.28%

% of portfolio

0.25%

Previous 0.31%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $36,084 - $41,102	340 Added 2.08%	16,705 $1.92 Million
Q2 2024 Aug 01, 2024	BUY	$92.57 - $107.37 $63,503 - $73,655	686 Added 4.38%	16,365 $1.74 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $61,068 - $69,529	-641 Reduced 3.93%	15,679 $1.52 Million
Q4 2023 Feb 07, 2024	BUY	$92.27 - $101.54 $75,384 - $82,958	817 Added 5.27%	16,320 $1.65 Million
Q3 2023 Oct 31, 2023	SELL	$94.73 - $105.13 $56,743 - $62,972	-599 Reduced 3.72%	15,503 $1.58 Million
Q2 2023 Aug 08, 2023	BUY	$92.52 - $104.91 $150,530 - $170,688	1,627 Added 11.24%	16,102 $1.62 Million
Q1 2023 May 10, 2023	BUY	$80.03 - $92.81 $40,735 - $47,240	509 Added 3.64%	14,475 $1.33 Million
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $109,698 - $134,339	1,452 Added 11.6%	13,966 $1.27 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $194,732 - $227,748	2,610 Added 26.35%	12,514 $951,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $285,604 - $332,531	3,547 Added 55.8%	9,904 $837,000
Q1 2022 Jun 08, 2022	BUY	$80.11 - $90.62 $308,022 - $348,433	3,845 Added 153.07%	6,357 $558,000
Q4 2021 Jun 07, 2022	BUY	$79.7 - $88.13 $200,206 - $221,382	2,512 New	2,512 $220,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.

Account

Vise Technologies, Inc. Novartis Ag Transaction History